Support & Guidance: Making Your Medication Journey Easier

Starting a new medication for obesity or weight management can feel like a big step, especially when it involves an injectable device. But with the right guidance, it becomes a simple routine that fits naturally into your day.

Understanding your device

Currently, GIP/GLP-1 agonist used for obesity management come in easy-to-use prefilled pens designed for self-injection. These devices are built for safety, precision, and comfort. That said, always follow your healthcare provider’s demonstration.

Learning the technique

Your doctor can guide you on where and how to inject (typically the abdomen, thigh, or upper arm). They may suggest rotating injection sites each time to reduce local skin reactions. Watching a step-by-step demo before your first use can make a big difference in building confidence.

Storage and handling

Keep the medication refrigerated but never frozen. If you’re traveling, store it in a cool pouch with ice packs and away from direct sunlight. Always check the expiry date and appearance before use. Do not inject if the solution looks cloudy or discolored.

When to seek help

If you’re unsure about the technique or notice irritation at the injection site, reach out to your doctor before your next dose. Regular follow-ups ensure the treatment remains safe and effective.

The bottom line

Support is always available from your doctor. With consistent guidance, most people find the process easier than expected and feel more empowered in their weight management journey.

Disclaimers: This initiative is solely for patient support. It has been created with an intention to provide, assistance and support to patients & NOT intended towards product promotion, NOR advertisement of any health care professionals or doctors.  Patients should be advised to consult and seek medical advice from their concerned doctor/ health care professional before starting any treatment/medicine/ diet plan. Any advice regarding the management of any medical condition is completely at the discretion of their consulting physician/doctor (Registered Medical Practitioner). Cipla limited makes no representations as to the efficacy, accuracy, appropriateness, or suitability of any specific tests, products, procedures, treatments, services, opinions, healthcare providers or other information that may be shared through this screening/program/activity. Cipla shall not be responsible for any direct, indirect, consequential or other damages arising therefrom. No personal data is being collected, stored, or processed by Cipla as a part of this initiative. Yurpeak®, KwikPen® and Lilly are registered trademark of Eli Lilly & Company, promoted and distributed by Cipla in India. The “CIPLA” mark and logo are the sole and intellectual property of Cipla Limited. Nothing on this website should be construed as giving medical advice or making recommendations regarding any health-related decision or action. You should consult a doctor or other qualified healthcare professional regarding any questions about your health or before making any treatment-related decisions. The contents of this site are not intended to substitute the medical judgment of your treating physicians. This website is intended for people over 18 years of age. This website is intended for the sole use of registered health care providers and patients prescribed with Yurpeak (tirzepatide) on their physician's advice. Yurpeak and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. Yurpeak is available by prescription only. To be sold by retail under prescription of Endocrinologist or Internal Medicine specialists only. For adverse events and safety reporting, please reach out to: drugsafety@cipla.com or report to Cipla Ltd. on 18002577779 For any additional information related to Lilly products, please reach out to: queries_in-medinfo@lilly.com.